Generex Biotechnology News

2,62 $ +0,38% +0,01 $
In Euro: 2,2602 € | 18.06.18 Nasdaq OTC Other | Mehr Kurse »
WKN: 922012
ISIN: US3714851033
US-Symbol: GNBT
Typ: Aktie

Generex Biotechnology News

  
25.01.17 Yutaka Niihara, MD, MPH, CEO of Emmaus, Appointed Executive Chairman of Generex Biotechnology Corporation PR Newswire
24.01.17 Emmaus Life Sciences, Inc. Enters into Collaborative Agreement with Generex Biotechnology Corporation PR Newswire
15.10.15 Generex Announces Memorandum of Understanding in respect of a Phase II Clinical Trial for the Antigen Express Prostate Cancer Vaccine PR Newswire
13.10.15 Generex Announces Agreement to Acquire Equity Interest in MediTemp Ltd. PR Newswire
06.10.15 Generex Announces Agreement to Acquire Equity Interest in Alfa Rhythm Ltd. PR Newswire
01.10.15 Generex Announces Issuance of Buccal Cannabis White Paper PR Newswire
30.09.15 Generex Announces Agreement to Acquire Equity Interest in Hema Diagnostic Systems PR Newswire
08.09.15 Generex Announces Commencement of Buccal Leuprolide R&D Work PR Newswire
02.09.15 Generex Announces Formalization of Buccal Cannabis Co-​Development Plan PR Newswire
27.08.15 Generex Announces Issuance of Buccal Insulin White Paper PR Newswire
25.08.15 Generex Provides Update on Success of Buccal Insulin Formulation Enhancement Project PR Newswire
06.08.14 Generex Announces Publication of AE37 Prostate Cancer Vaccine Study PR Newswire
17.06.14 Generex Announces Interview of Dr. Eric von Hofe, President of Antigen Express, Following Recent Keynote Presentation PR Newswire
12.06.14 Generex/Antigen Express Announce Interview of MD Anderson's Dr. Elizabeth Mittendorf, Principal Investigator on Company's AE37 Phase IIb Breast Cancer Efficacy Trial PR Newswire
10.06.14 Generex / Antigen Express to Participate in 2014 BIO International Convention PR Newswire
20.05.14 Generex Announces Presentation of Primary Efficacy Data & Immunological Response from the Phase II Study of AE37 Cancer Vaccine at ASCO PR Newswire
30.04.14 Generex Announces Antigen Express AE37 Breast Cancer Vaccine Abstract Presentations at ASCO 2014 Annual Meeting PR Newswire
25.04.14 Generex Announces Antigen Express AE37 Breast Cancer Vaccine Abstract Presentations at ASCO 2014 Annual Meeting PR Newswire
27.03.14 Generex Announces $2,075,000 Capital Investment PR Newswire
26.03.14 Generex/Antigen Express Announces Participation on Panel at Upcoming Cancer Immunotherapeutics Symposium PR Newswire
05.03.14 Generex Subsidiary Antigen Express Receives Patents for Vaccines Targeting HPV Induced Cancers and Influenza PR Newswire
27.02.14 Generex Announces Publication of Biomarker Studies Related to the Antigen Express Novel Immunotherapeutic AE37 in Prostate Cancer Patients PR Newswire
12.02.14 Generex Provides Update on Antigen Express Phase II AE37 Breast Cancer Vaccine Trial PR Newswire
04.02.14 Generex/Antigen Express "Stock News Now" Interview Available Online PR Newswire
13.01.14 Generex Announces Completion of Enrollment of Antigen Express Phase II AE37 Breast Cancer Vaccine Trial PR Newswire
09.01.14 Generex Announces Selection of Antigen Express Technology for Keynote Presentation at 2014 TIDES Conference PR Newswire
06.01.14 Generex/Antigen Express Announce Database Lock of AE37 Breast Cancer Vaccine Trial PR Newswire
18.11.13 Antigen Express AE37 Breast Cancer Vaccine Update PR Newswire
27.09.13 Generex Provides Update on Generex Oral-lyn™ Conference Call PR Newswire
20.08.13 Generex Announces Publication of Follow-up Studies from Phase I Trial of Novel Immunotherapeutic in Prostate Cancer Patients PR Newswire
13.08.13 Generex Announces Podium Presentation on Antigen Express Cancer Vaccine Strategy PR Newswire
12.08.13 Generex Provides Call-In Details for Conference Call with Members of the Antigen Express Scientific Advisory Board PR Newswire
23.07.13 Generex Confirms Conference Call with Members of the Antigen Express Scientific Advisory Board PR Newswire
12.07.13 Generex Announces Particulars of Conference Call with Members of the Antigen Express Scientific Advisory Board PR Newswire
10.07.13 Generex Oral-lyn™ Results in More Rapid Reductions of HbA1c in Shreya's Phase III Study of Type 2 Diabetes in India PR Newswire
08.07.13 Generex Announces Conference Call with Members of Generex Oral-lyn™ and Diabetes Program Team PR Newswire
03.07.13 Generex Announces Amendment of Form S-1 PR Newswire
01.07.13 Generex Announces Conference Call with Members of the Antigen Express Scientific Advisory Board PR Newswire
17.06.13 Generex Announces $1,225,000 Capital Investment PR Newswire
13.06.13 ASCO Interview of MD Anderson's Mittendorf on AE37 Breast Cancer Vaccine Now Available on Generex Websites PR Newswire
12.06.13 Generex Announces Interview of MD Anderson's Dr. Elizabeth Mittendorf, Principal Investigator on Company's AE37 Phase IIb Breast Cancer Efficacy Trial PR Newswire
05.06.13 Generex Announces ASCO Presentations of AE37 Vaccine Data; Potential Leading Immunotherapy Option for Breast Cancer Patients PR Newswire
31.05.13 Positive Generex Data Underscores Cancer Immunotherapy Forecast Issued by Citi PR Newswire
22.05.13 Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine PR Newswire
03.04.13 Generex Comments on Results of Stockholders` Meeting PR Newswire
07.02.13 Generex Touts Pipeline Potential of Antigen Express Subsidiary PR Newswire
31.01.13 Generex Points to Potential of Antigen Express Technology Platform beyond Its AE37 Breast Cancer Vaccine PR Newswire
30.01.13 Generex Provides an Overview of its Cancer Immunotherapy Product, AE37, and Potential in Early Breast Cancer Given Current and Potential Future Therapies PR Newswire
29.01.13 Generex Announces Details of Investor Conference Call PR Newswire
23.01.13 Generex Oral-lyn™ Phase III Dossier Submitted To Indian Government For Marketing Approval PR Newswire

Newssuche

  

Videos

  
06:41 Uhr
NYSEinstein am 19.6.2018: "Kluge Männer bauen Brücken, dumme bauen Mauern"